scholarly journals Prognostic significance of urine cytology on initial follow-up after intravesical mitomycin C for superficial bladder cancer

Cancer ◽  
1986 ◽  
Vol 57 (11) ◽  
pp. 2119-2122 ◽  
Author(s):  
John D. Cant ◽  
William M. Murphy ◽  
Mark S. Soloway
Keyword(s):  
Bladder Cancer ◽  
Mitomycin C ◽  
Superficial Bladder Cancer ◽  
Prognostic Significance ◽  
Urine Cytology

832: Optimized Intravesical Mitomycin C Treatment for Superficial Bladder Cancer: Long-Term Follow-Up

2006 ◽  
Vol 175 (4S) ◽  
pp. 268-269 ◽  
Author(s):  
Jessie L. Au ◽  
Robert A. Badalament ◽  
M. Guillaume Wientjes ◽  
Donn C. Young ◽  
Tong Shen ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Mitomycin C ◽  
Superficial Bladder Cancer ◽  
Long Term Follow Up

A randomized trial of fenretinide in superficial bladder cancer: 20 year follow-up and prognostic significance of VEGF.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. e15500-e15500
Author(s):  
Marilena Petrera ◽  
Matteo Puntoni ◽  
Sara Campora ◽  
Carlotta Defferrari ◽  
Rosalba Torrisi ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Randomized Trial ◽  
Superficial Bladder Cancer ◽  
Prognostic Significance

Mitomycin C in Superficial Bladder Cancer: 24-month Follow-up

1985 ◽  
Vol 57 (6) ◽  
pp. 686-689 ◽  
Author(s):  
J. J. F. SOMERVILLE ◽  
D. W. W. NEWLING ◽  
B. RICHARDS ◽  
M. R. G. ROBINSON ◽  
P. H. SMITH
Keyword(s):  
Bladder Cancer ◽  
Mitomycin C ◽  
Superficial Bladder Cancer

Endovesical Prophylactic Mitomycin C Chemotherapy in Superficial Bladder Cancer: A Retrospective Study

1993 ◽  
Vol 60 (4) ◽  
pp. 320-324 ◽  
Author(s):  
C. Boccafoschi ◽  
D. Tiranti ◽  
F. Montefiore ◽  
S. Annoscia ◽  
A. Di Mauro ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Retrospective Study ◽  
Mitomycin C ◽  
Patient Group ◽  
Prophylactic Treatment ◽  
Superficial Bladder Cancer ◽  
Progression Rate ◽  
Recurrent Carcinoma

The Authors report the results of a retrospective study concerning the use of mitomycin C in the prophylactic treatment of superficial bladder cancer after trans-urethral resection. The series includes 113 patients; minimum follow-up: 6 months, maximum 54, mean 17.7 months. Recurrence and progression rate was evaluated at 6, 12, 24, and 36 months. The cumulative recurrence and progression rate was 16.8% and 6.1% respectively. Patients with pTa neoplasms didn't develop progressions. G2 and G3 carcinoma recurrence and progression rate was higher than with G1 tumours. Multifocal neoplasms showed a higher trend recurrence compared to solitary tumours. The number of recurrences in the patient group with primitive neoplasms was not significantly different from that of patients with recurrent carcinoma.

277: Long Term Follow Up of a Randomised Study of BCG Versus Mitomycin-C in High Risk Superficial Bladder Cancer

2004 ◽  
Vol 171 (4S) ◽  
pp. 73-73 ◽  
Author(s):  
Truls Gårdmark ◽  
Per-Uno Malmstrom ◽  
Peter Wiklund ◽  
Staffan Jahnson ◽  
Hans Wijkström ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
High Risk ◽  
Mitomycin C ◽  
Superficial Bladder Cancer ◽  
Randomised Study ◽  
Long Term Follow Up
Sign in / Sign up

Export Citation Format

Share Document